A randomized trial to investigate the efficacy and safety of once‐daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg

AIMS/INTRODUCTION: The present trial compared the efficacy and safety of once‐daily liraglutide 1.8 mg with liraglutide 0.9 mg in Japanese patients with type 2 diabetes to assess the incremental effects of liraglutide 1.8 mg in those who exhibited an inadequate response to 0.9 mg. MATERIALS AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Seino, Yutaka, Miyoshi, Hideaki, Bosch Traberg, Heidrun, Divyalasya, T V S, Nishijima, Keiji, Terauchi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340870/
https://www.ncbi.nlm.nih.gov/pubmed/35285173
http://dx.doi.org/10.1111/jdi.13789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340870/
https://www.ncbi.nlm.nih.gov/pubmed/35285173
http://dx.doi.org/10.1111/jdi.13789

Ejemplares similares